Home Duke University Press
QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

First published on June 10, 2008
This version was published on August 1, 2008
Neuro Oncol 2008 10(4):540-547; DOI:10.1215/15228517-2008-022
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
10/4/540    most recent
15228517-2008-022v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Idbaih, A.
Right arrow Articles by Delattre, J.-Y.
PubMed
Right arrow PubMed Citation
Duke University Press

Basic and Translational Investigations

Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas

Ahmed Idbaih, Emmanuelle Crinière, Yannick Marie, Audrey Rousseau, Karima Mokhtari, Michèle Kujas, Younas El Houfi, Catherine Carpentier, Sophie Paris, Blandine Boisselier, Florence Laigle-Donadey, Joëlle Thillet, Marc Sanson, Khê Hoang-Xuan and Jean-Yves Delattre

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 711, and Université Pierre et Marie Curie-Paris 6, Laboratoire Biologie des Interactions Neurone-Glie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France (A.I., E.C., Y.M., A.R., K.M., M.K., Y.E.H., C.C, S.P., B.B., F.L-D., J.T., M.S., K.H-X., J-Y.D.); Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie Mazarin, Paris, France (A.I., F.L-D., M.S., K.H-X., J-Y.D.); AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Laboratoire de Neuropathologie R. Escourolle, Paris, France (A.R., K.M., M.K.)

Address correspondence to Dr. Ahmed Idbaih, INSERM U711, Université Pierre et Marie Curie, Laboratoire Biologie des Interactions Neurone-Glie and Service de Neurologie Mazarin, Hôpital Pitié-Salpêtrière, 47-83, Boulevard de l'Hôpital, 75013 Paris, France (ahmed.idbaih{at}gmail.com).

Various gene amplifications have been observed in gliomas. Prognostic-genomic correlations testing simultaneously all these amplified genes have never been conducted in anaplastic oligodendrogliomas. A set of 38 genes that have been reported to be amplified in gliomas and investigated as the main targets of amplicons were studied in a series of 52 anaplastic oligodendrogliomas using bacterial artificial chromosome-array based comparative genomic hybridization and quantitative polymerase chain reaction. Among the 38 target genes, 15 were found to be amplified in at least one tumor. Overall, 27% of anaplastic oligodendrogliomas exhibited at least one gene amplification. The most frequently amplified genes were epidermal growth factor receptor (EGFR) and cyclin-dependent kinase 4/sarcoma amplified sequence (CDK4/SAS) in 17% and 8% of anaplastic oligodendrogliomas, respectively. Gene amplification and codeletion of chromosome arms 1p/19q were perfectly exclusive (p = 0.005). In uni- and multivariate analyses, gene amplification was a negative prognostic factor for progression-free survival and overall survival in anaplastic oligodendrogliomas, providing complementary information to the classic prognostic factors identified in anaplastic oligodendrogliomas (extent of surgery, KPS, and chromosome arms 1p/19q status).

Key Words: amplification • anaplastic • gene • oligodendroglioma • prognosis






  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2008 by Society for Neuro-Oncology